Quantum-Enabled EPR For Structural Biology And Drug Discovery

Capturing dynamic conformational states, transient intermediates, and structural disorder remains a fundamental challenge in structural biology and drug discovery. Conventional methods such as X-ray crystallography, Cryo-EM, and computational models frequently miss low-population dynamics that govern target druggability. Integrating quantum-enabled electron paramagnetic resonance (EPR) spectroscopy into experimental workflows delivers high-resolution distance distributions across a range of 2 to 8 nanometers, providing vital ensemble validation for complex protein systems.

Automated instrumentation and flexible sample measurement services streamline access to publication-ready dynamics data without requiring specialized internal expertise. Enhanced phase stability enables extended signal averaging for low-concentration samples, difficult targets, and subtle conformational shifts across biomolecules, including membrane proteins, nucleic acids, and CRISPR complexes. Explore the flyer to evaluate how advanced EPR workflows and measurement services accelerate target characterization.